Clinical trial

Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide

NCT06083116

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-08-28

PhasePHASE1

Study timeline

Study start (actual)2019-08-28Date precision: day

Registry last updated2023-10-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes in Adultsunresolved

Interventions

Hydrochlorothiazide、Henagliflozin ProlineDRUG

Sponsors & collaborators

Jiangsu HengRui Medicine Co., Ltd.lead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06083116 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.